Les Recio PhD, DABT

Dr. Recio is responsible for defining the scope of work, providing oversight and organization for all studies, and training ILS staff in genetic and molecular toxicology methods. He provides supervision of all genetic toxicology and genomic-based projects through prioritization, coordination and scheduling of all activities. He also guides the development of new capabilities for novel approaches for use in the assessment of genotoxicity, and works with ILS staff to develop new programs and provide new avenues for research projects. He received both his M.S. and Ph.D. in Toxicology from the University of Kentucky. Dr. Recio has published more than 100 manuscripts in the peer-reviewed literature examining mode-of-action and identification of biomarkers of cytotoxicity, genotoxicity, and mutagenicity. Dr Recio served on board of Councilors for the North Carolina Chapter of the Society of Toxicology (2006-2008), and in 2006 was the President of the Genetic and Environmental Mutagenesis Society. In 2010, was appointed to the SOT Council on Diversity Initiatives and in 2012 elected President for the SOT’s Hispanic Organization for Toxicologist. In 2012 -2015 appointed to an OECD Expert Group charged with revising OECD 476 and the development of a new OECD Guidance on TK gene mutation (OECD 490). Dr Recio serves on the Editorial Board for Mutation Research – Reviews in Mutation Research and is an Associate Editor for Toxicological Sciences.